Encompass Total Liab vs Long Term Debt Total Analysis
EHC Stock | USD 102.94 0.10 0.1% |
Encompass Health financial indicator trend analysis is much more than just examining Encompass Health Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Encompass Health Corp is a good investment. Please check the relationship between Encompass Health Total Liab and its Long Term Debt Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Total Liab vs Long Term Debt Total
Total Liab vs Long Term Debt Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Encompass Health Corp Total Liab account and Long Term Debt Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Encompass Health's Total Liab and Long Term Debt Total is 0.89. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of Encompass Health Corp, assuming nothing else is changed. The correlation between historical values of Encompass Health's Total Liab and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Encompass Health Corp are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Total Liab i.e., Encompass Health's Total Liab and Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | 0.89 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Long Term Debt Total
Most indicators from Encompass Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Encompass Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At present, Encompass Health's Enterprise Value Over EBITDA is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 9.74, whereas Selling General Administrative is forecasted to decline to about 191.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.9B | 4.1B | 933.5M | 886.8M | Total Revenue | 5.1B | 4.3B | 4.8B | 2.8B |
Encompass Health fundamental ratios Correlations
Click cells to compare fundamentals
Encompass Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Encompass Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.1B | 6.4B | 6.9B | 5.6B | 6.1B | 3.8B | |
Short Long Term Debt Total | 3.3B | 3.5B | 3.5B | 3.0B | 2.9B | 2.2B | |
Other Current Liab | 506.3M | 474.4M | 510.1M | 366.6M | 437.5M | 380.4M | |
Total Current Liabilities | 721M | 717.3M | 748.8M | 575.9M | 656.4M | 512.4M | |
Total Stockholder Equity | 1.4B | 1.6B | 1.9B | 1.3B | 1.6B | 1.7B | |
Property Plant And Equipment Net | 2.2B | 2.5B | 2.8B | 3.2B | 3.5B | 3.7B | |
Net Debt | 3.3B | 3.3B | 3.5B | 3.0B | 2.9B | 2.1B | |
Retained Earnings | (526.5M) | (242.3M) | 141.8M | 115.7M | 406.5M | 426.8M | |
Cash | 94.8M | 224M | 54.8M | 21.8M | 69.1M | 111.7M | |
Non Current Assets Total | 5.3B | 5.5B | 5.9B | 4.9B | 5.3B | 3.0B | |
Non Currrent Assets Other | 213.8M | 295M | 254.5M | (13.3M) | 82.1M | 78.0M | |
Cash And Short Term Investments | 94.8M | 224M | 54.8M | 21.8M | 69.1M | 116.9M | |
Net Receivables | 506.1M | 572.8M | 502.1M | 536.8M | 611.6M | 436.2M | |
Liabilities And Stockholders Equity | 6.1B | 6.4B | 6.9B | 5.6B | 6.1B | 3.8B | |
Non Current Liabilities Total | 3.4B | 3.7B | 3.7B | 3.2B | 3.1B | 2.4B | |
Inventory | 57.4M | 65.4M | 65.1M | 31.6M | 72.7M | 77.7M | |
Other Current Assets | 154.9M | 151.8M | 369.9M | 170.6M | 161.1M | 168.3M | |
Other Stockholder Equity | 1.9B | 1.8B | 1.8B | 1.2B | 1.2B | 1.8B | |
Total Liab | 4.1B | 4.4B | 4.5B | 3.8B | 3.8B | 2.9B | |
Property Plant And Equipment Gross | 2.2B | 2.5B | 2.8B | 3.2B | 5.4B | 5.7B | |
Total Current Assets | 755.8M | 948.6M | 921.4M | 717.2M | 841.8M | 734.0M | |
Short Term Debt | 120.1M | 127.9M | 104.7M | 76.4M | 48.9M | 59.2M | |
Intangible Assets | 476.3M | 431.3M | 417.5M | 282.3M | 278.2M | 222.5M | |
Current Deferred Revenue | 242.9M | 300.9M | 310.3M | 83M | 42.6M | 40.5M | |
Accounts Payable | 94.6M | 115M | 134M | 132.9M | 170M | 178.5M | |
Other Liab | 159.9M | 266.8M | 259.9M | 257.2M | 231.5M | 172.7M | |
Other Assets | 300.2M | 542M | 254.5M | 222.1M | 1.0 | 0.95 | |
Long Term Debt | 3.0B | 3.3B | 3.2B | 2.7B | 2.7B | 2.0B | |
Treasury Stock | (427.9M) | (492.3M) | (497.4M) | (521.2M) | (469.1M) | (492.5M) | |
Property Plant Equipment | 2.0B | 2.5B | 2.8B | 3.2B | 3.6B | 3.8B | |
Good Will | 2.3B | 2.3B | 2.4B | 1.3B | 1.3B | 1.3B | |
Net Tangible Assets | (1.2B) | (699.1M) | (934.1M) | (235.2M) | (211.7M) | (222.3M) | |
Warrants | 261.7M | 239.6M | 31.6M | 42.2M | 38.0M | 36.1M | |
Noncontrolling Interest In Consolidated Entity | 280.3M | 340.9M | 382M | 445.7M | 512.6M | 538.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.26 | Dividend Share 0.62 | Earnings Share 4.25 | Revenue Per Share 52.255 | Quarterly Revenue Growth 0.119 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.